EMERGENCY TELEPHONE NUMBER:
1-406-827-3523
*****************************************************************
|
NAME USED ON
LABEL: |
MONTANA BRAND HT
MONTANA BRAND
HTW
MONTANA BRAND MP
MONTANA BRAND
MPW |
MONTANA BRAND LT
MONTANA BRAND
LTW
MONTANA BRAND VF
MONTANA BRAND
VFW |
|
CHEMICAL NAME: |
Antimony
Trioxide |
|
CHEMICAL FAMILY: |
Antimony
Compound |
|
FORMULA: |
Antimony
Compound |
|
DOT SHIPPING
NAME: |
Non-Hazardous
Flame Retardant |
|
ITEM NO: |
50155 |
|
SUB NO: |
4 |
|
DOT HAZARD
CLASS: |
50 |
|
ISSUE DATE: |
January 1, 2011 |
INGREDIENTS
|
IDENTITY |
CAS NO. |
TYPICAL % |
TWA |
ACGIH STEL |
OSHA PEL |
|
Antimony
Trioxide |
1309-64-4 |
>99.5 |
0.5mg/m3 as Sb |
none |
0.5mg/m3 as Sb |
|
Arsenic |
7440-38-2 |
<0.10 |
0.01mg/m3 as As |
|
0.01mg/m3 as As |
|
Lead |
|
<0.10 |
0.05mg/m3 as Pb |
|
0.05mg/m3 as Pb |
PHYSICAL DATA
|
BOILING POINT @
760 HG |
2597 F |
|
VAPOR DENSITY
(AIR-1) |
Not Applicable |
|
SPECIFIC GRAVITY
(H20) |
Not Applicable |
|
Ph OF SOLUTIONS |
Not Applicable |
|
FREEZING/MELTING
POINT |
Not Applicable |
|
SOLUBILITY
(WEIGHT % IN WATER) |
Slight |
|
BULK DENSITY |
Unknown |
|
VOLUME %
VOLATILE |
Not Applicable |
|
EVAPORATION RATE |
Not Applicable |
|
HEAT OF SOLUTION |
Not Applicable |
|
APPEARANCE AND
ODOR |
Fine White
Powder/Odorless |
FIRE AND EXPLOSION DATA
|
FLASH POINT |
None |
|
FLAMMABLE LIMITS
IN AIR (% BY VOLUME) |
Not Applicable |
|
EXTINGUISHING
MEDIA |
Not Applicable |
|
SPECIAL FIRE
FIGHTING PROCEDURES |
Not Applicable |
|
UNUSUAL FIRE AND
EXPLOSION HAZARDS |
Not Applicable |
HEALTH HAZARD DATA
|
PERMISSIBLE EXPOSURE LIMITS (TLV) |
The permissible
exposure limit for antimony is 0.5mg/m3 as Sb-8 hour TWA,
OSHA 29CFR 1910.1000 (May 28,1975) |
|
TOXICITY DATA |
|
|
LC-50 INHALATION |
See “Effects of
Overexposure” section |
|
LD-50 DERMAL |
(rabbits) >
2g/kg |
|
LD-50 INGESTION |
(rats) >34.6g/kg |
|
LC-50 FISH
(LETHAL CONCENTRATION) |
Unknown |
|
HUMAN EXPOSURE
INFORMATION/DATA |
TLV-TWA for As
is .2mg/m3
TLV-TWA FOR Zinc
Oxide is 10mg/m3
See “Effects of
Overexposure” section |
|
|
|
|
CLASSIFICATION (POISON, IRRITANT, ETC) |
|
|
INHALATION |
See “Effects of
Overexposure” section |
|
SKIN/EYE |
Moderately
irritating to skin and eyes |
|
INGESTION |
Not
significantly toxic |
|
AQUATIC |
Unknown |
REACTIVITY DATA
|
STABILITY |
Stable |
|
CONDITIONS TO
AVOID |
None known |
|
HAZARDOUS
POLYMERIZATION |
Will not occur |
|
INCOMPATIBILITY
(MATERIALS TO AVOID) |
None known |
|
HAZARDOUS
DECOMPOSITION PRODUCTS |
Not applicable |
EFFECTS OF OVEREXPOSURE
This section covers the effects of
overexposure for inhalation, eye/skin contact, ingestion and other
types of overexposure information in the order of the most hazardous
and the most likely rout of overexposure.
INHALATION
Animal test (rats) @ 2.7mg/1 (2,760mg/m3) exposure for four
hours produced no deaths. Gross pathological alterations found were
slight focal discoloration and slight puffy white foci in the lungs.
ACUTE EFFECTS
Inhalations: Antimony oxide
inhalation can cause irritation to the respiratory tract and mucous
membranes.
Eye contact: Antimony oxide was found
to be slightly - moderately irritating. Therefore, eye contact can
cause
irritation and pain.
Skin contact: Antimony oxide was found to
be minimally irritating to the skin when tested on laboratory
animals.
However, human experience indicates that prolonged or repeated
contact with skin can result in
irritation and skin lesions, sometimes referred to as “antimony
fleas”. Skin irritation is worse when
the skin surface is moist as found with perspiration
CHRONIC EFFECTS
The primary route of chronic
overexposure to antimony oxide is by inhalation. Various studies of
human overexposure to various forms of antimony in smelters reported
effects primarily including
dermatitis, rhinitis, inflammation of the upper and lower
respiratory tract (including pneumonitis),
with a few cases of gastritis, conjunctivitis, and sepal
perforation.
Studies on animals
exposed to antimony tri-sulfide have been reported to cause changes
in the
heart (EKG’s). However, no such reports have been
reviewed to suggest similar alterations
in EKG’s from exposure to antimony tri-oxide.
Preliminary data from two independent chronic rat inhalation studies
revealed antimony oxide induced both benign and malignant lung
tumors in animal exposed for at least 12 months to concentration at
4.2 and 50 mg/m3. Animals exposed to 1.6mg/m3 have not shown a
carcinogenic response to date. The tumors represented an unusual
histological appearance from lesions previously described in rat
lungs. A high incidence of lung fibrosis was also associated with
exposure.
Antimony
oxide and antimony compounds should be handled as suspect
carcinogens because of these findings. Antimony oxide is an I.A.R.C.
(Group IIB) suspect carcinogen and arsenic is and OSHA cancer
hazard, an NTP Human Carcinogen, and an I.A.R.C. (Group I) Human
Carcinogen.
AFFECTS OF ACUTE
AND CHRONIC OVEREXPOSURE (ARSENIC)
|
Primary route of
entry: |
Inhalation
Ingestion
Skin Contact |
|
Inhalation can
cause: |
Can affect the
heart, liver & kidney. Toxic symptoms include nervousness,
vomiting, thirst, diarrhea, cyanosis, & collapse |
|
Ingestion can
cause: |
Same as above
plus GI tract irritation |
|
Skin contact can
cause: |
Ulcerations |
AFFECTS OF ACUTE
AND CHRONIC OVEREXPOSURE (LEAD)
|
Primary route of
entry: |
Inhalation
Ingestion
Skin Contact
Eye Contact |
|
Inhalation can
cause: |
Respiratory
irritation, weakness, vomiting, loss of appetite, loss of
coordination, convulsions, stupor coma |
|
Ingestion can
cause: |
Same as above |
|
Skin contact can
cause: |
Same as above |
|
Eye contact can
cause: |
Same as above |
Left
untreated can lead to weakness, insomnia, hypertension, irritation
to skin and eye, anemia, metallic taste, constipation, headache,
muscle and joint pain, neuromuscular dysfunction, paralysis,
encephalopathy, peripheral neuropathy.
EMERGENCY AND FIRST AID PROCEDURES
|
INHALATION |
Remove to fresh
air. If not breathing, give artificial respiration,
preferable mouth-to-mouth. If breathing is difficult, give
oxygen. Call physician. |
|
SKIN CONTACT |
Flush skin with
plenty of water. If irritation occurs consult a physician. |
|
EYE CONTACT |
Flush eyes
thoroughly with water for at least 15 minutes. Call
physician. |
|
INGESTION |
(Swallowing)
Drink a quart of water the induce vomiting by placing a
finger far back in the throat. Call a physician. If vomiting
cannot be induced take immediately to a physician or a
hospital. Do not induce vomiting or give anything by mouth
to an unconscious person. |
SPILL OR LEAK PROCEDURES
Steps to
be taken if material is spilled or released:
Vacuum all visible spilled materials and place
in closed plastic bags for disposal. Thoroughly flush area of spill
with water. Water flush should be used only after all visible
material has been vacuumed. DO NOT flush spilled material to sewer.
Waster
Disposal Method:
Care must be taken when using or disposing of
chemical materials and/or their containers to prevent environmental
contamination. It is your duty to dispose of the chemical materials
and/or their containers in accordance with the Clean Air Act, the
Clean Water Act, the Resource Conservation and Recovery Act and all
state and local laws/regulations regarding disposal.
SPECIAL PROTECTION INFORMATION
|
Respiratory
Protection |
NIOSH/MSHA
approved dust respirator. Respiratory program must be in
accordance with 29CFR 1910.134. |
|
Ventilation Type |
Local
Exhaust-Sufficient to maintain employee exposure as far
below OSHA permissible exposure limits as practical. |
|
Eye Protection |
Chemical Safety
Goggles |
|
Gloves |
Rubber, Neoprene
or Nitrile |
|
Other Protective
Equipment |
Long sleeved
shirt, eye-wash fountain and safety shower in immediate
area. Personnel protective clothing and use of equipment
must be in accordance with 29CFR 1910.133. |
SPECIAL PRECAUTIONS
Precautions to be taken during handling and storing:
-
When
handling wear long sleeved shirt, rubber gloves and chemical
safety goggles.
-
Wear
respiratory protection where potential exposure to dust may
occur.
-
Respiratory protection must be NIOSH/MSHA approved for
protection against dust.
-
Store in a
dry, well-ventilated area.
-
Do not
store in open, unlabeled or mislabeled containers.
Other
precautions:
-
Do not
inhale dust. Inhalation may cause irritation of respiratory
tract and mucous membranes. Long-term exposure may cause
irreversible lung changes and other health effects.
-
Use only
with adequate ventilation. Ventilation must be sufficient to
limit employee exposure to antimony oxide in work area as far
below OSHA permissible exposure limit as practical.
-
Avoid
contact with eyes. May cause irritation and pain.
-
Do not
take internally.
-
Do not eat
or drink in work area.
-
Wash
thoroughly after handling and take shower at end of work shift.
Wear clean clothing daily.
ADDITIONAL INFORMATION
|
CLASSIFICATIONS |
|
Sara Title III |
HMIS FLAMM |
NFPA FLAMM |
|
Acute: Y
Chron: Y
Press: Y
React: Y
Fire: Y |
React:
Health:
PPE: |
React: 0
Health: 0 |
|
Components of
this product which appear in the ingredients section of this
MSDS are identified below if they are present in excess of
the minimum reporting levels. Components which are not
required to be identified by specific chemical name may have
a generic description. |
|
SARA TITLE III |
Section 302
Extremely Hazardous Substance (s): |
None |
|
SARA TITLE III |
Section 313
Toxic Chemicals |
Antimony Oxide |
|
STATE
RIGHT TO KNOW |
|
Components of
this product which are specifically identified in the
ingredients section of this MSDS may be listed on the
following:
-
Pennsylvania
Hazardous Substance List
-
Massachusetts
Hazardous Substance List
-
California
Proposition 65 – This product contains a chemical known
by the State of California to cause cancer and a
chemical also known by the State of California to be a
reproductive toxin.
|
|
TSCA INVENTORY |
|
Antimony oxide is reported in EPA TSCA inventory, 1980. Rev.
6: 19 May, 2003
REFERENCES
-
Acute Toxicity
Studies with Antimony Trioxide, Industrial Bio-Test
Laboratories, Inc., Northbrook, Illinois,
60062, Keplinger, et al., Report Nos. T-2298 and A-2297,
Nov./Dec. 1972
-
Industrial Hygiene
and Toxicology, Second Edition, Frank A. Patty, 1962
-
Occupational
Exposure to antimony, NIOSH Criteria Document, U.S.
Department of HEW, September, 1978
-
WIL Research
Laboratory, Study # WIL-1277-79, Acute Eye Irritation in
Rabbits with Antimony Oxide, December 21, 1979
-
Assessment of
Carcinogenicity of Antimony Trioxide, experimental
Pathology Laboratory, Inc., Herndon, Virginia, August,
1980
|
